Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis

por Reiss, William G., Devenport, Jenny N., Low, Jason M., Wu, George, Sasso, Eric H.
Publicado 2015

Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subject...

por Curtis, Jeffrey R., Wright, Grace C., Strand, Vibeke, Davis, Charles S., Hitraya, Elena, Sasso, Eric H.
Publicado 2017

Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT

por Gladman, Dafna D, Mease, Philip J, Choy, Ernest HS, Ritchlin, Christopher T, Perdok, Renee J, Sasso, Eric H
Publicado 2010

Does the multi-biomarker disease activity score have diagnostic value in early rheumatoid arthritis and unclassified arthritis?

por Maijer, Karen I, Li, Wanying, Sasso, Eric H, Gerlag, Daniëlle M, Defranoux, Nadine A, Tak, Paul P
Publicado 2015

Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis

por Li, Wanying, Sasso, Eric H., van der Helm-van Mil, Annette H. M., Huizinga, Tom W. J.
Publicado 2016

ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation

por Boeters, Debbie M., Burgers, Leonie E., Sasso, Eric H., Huizinga, Tom W. J., van der Helm – van Mil, Annette H. M.
Publicado 2019

Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgi...

por Lee, Yvonne C., Hackett, James, Frits, Michelle, Iannaccone, Christine K., Shadick, Nancy A., Weinblatt, Michael E., Segurado, Oscar G., Sasso, Eric H.
Publicado 2016

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial

por Hambardzumyan, Karen, Bolce, Rebecca J, Saevarsdottir, Saedis, Forslind, Kristina, Wallman, Johan K, Cruickshank, Scott E, Sasso, Eric H, Chernoff, David, van Vollenhoven, Ronald F
Publicado 2016

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial

por Hambardzumyan, Karen, Bolce, Rebecca, Saevarsdottir, Saedis, Cruickshank, Scott E, Sasso, Eric H, Chernoff, David, Forslind, Kristina, Petersson, Ingemar F, Geborek, Pierre, van Vollenhoven, Ronald F
Publicado 2015

Brief Report: Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi‐Biomarker Disease Activity Score as an Inclusion Criterion

por van Vollenhoven, Ronald F., Bolce, Rebecca, Hambardzumyan, Karen, Saevarsdottir, Saedis, Forslind, Kristina, Petersson, Ingemar F., Sasso, Eric H., Hwang, C. C., Segurado, Oscar G., Geborek, Pierre
Publicado 2015

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients

por Curtis, Jeffrey R., Xie, Fenglong, Crowson, Cynthia S., Sasso, Eric H., Hitraya, Elena, Chin, Cheryl L., Bamford, Richard D., Ben-Shachar, Rotem, Gutin, Alexander, Flake, Darl D., Mabey, Brent, Lanchbury, Jerry S.
Publicado 2020

Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies

por Curtis, Jeffrey R., Weinblatt, Michael E., Shadick, Nancy A., Brahe, Cecilie H., Østergaard, Mikkel, Hetland, Merete Lund, Saevarsdottir, Saedis, Horton, Megan, Mabey, Brent, Flake, Darl D., Ben-Shachar, Rotem, Sasso, Eric H., Huizinga, T. W.
Publicado 2021

The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies

por Roodenrijs, Nadia M. T., de Hair, Maria J. H., Wheater, Gill, Elshahaly, Mohsen, Tekstra, Janneke, Teng, Y. K. Onno, Lafeber, Floris P. J. G., Hwang, Ching Chang, Liu, Xinyu, Sasso, Eric H., van Laar, Jacob M.
Publicado 2018

Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis

por Curtis, Jeffrey R, Flake, Darl D, Weinblatt, Michael E, Shadick, Nancy A, Østergaard, Mikkel, Hetland, Merete Lund, Brahe, Cecilie Heegaard, Hwang, Yong Gil, Furst, Daniel E, Strand, Vibeke, Etzel, Carol J, Pappas, Dimitrios A, Wang, Xingbin, Hwang, Ching Chang, Sasso, Eric H, Gutin, Alexander, Hitraya, Elena, Lanchbury, Jerry S
Publicado 2019

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment

por Ghiti Moghadam, Marjan, Lamers-Karnebeek, Femke B. G., Vonkeman, Harald E., ten Klooster, Peter M., Tekstra, Janneke, Schilder, Annemarie M., Visser, Henk, Sasso, Eric H., Chernoff, David, Lems, Willem F., van Schaardenburg, Dirk-Jan, Landewe, Robert, Bernelot Moens, Hein J., Radstake, Timothy R. D. J., van Riel, Piet L. C. M., van de Laar, Mart A. F. J., Jansen, Tim L.
Publicado 2018